RxDoctor Payments Data

Eugene Alford, MD

Otolaryngology/Facial Plastic Surgery · Houston, TXNPI 1093700387

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 12 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 9 manufacturers, the largest accounting for just 23.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $334 and has fallen 90.1% since, to $33 in 2025. That places this record below the midpoint for otolaryngology/facial plastic surgery clinicians in TX, where the typical reported total is $1,846.

$738in general payments, 2019–2025

Across 12 payments — averaging $61.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Merz North America, Inc.$176
  • Mentor Worldwide LLC$162
  • Wound Management Technologies, Inc$118
  • Zimmer Biomet$115
  • Musculoskeletal Transplant Foundation Inc.$48
  • Baxter Healthcare$36
  • plus $81 from 3 others

What the payments were for

  • Food & beverage$738100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$738 in reported general payments places this provider in the 25th percentile of 51 otolaryngology/facial plastic surgery providers in Texas.

See all otolaryngology/facial plastic surgery providers in Texas

Medicare billing

Part B allowed, 2024
$19,462
Medicare patients
43
Services billed
72

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Celecoxib15$709
Doxycycline Hyclate18$153
Ondansetron OdtOndansetron14$123
Methylprednisolone22$86
Gabapentin20$43
Mupirocin11$38
Tramadol Hcl16$26

Paid to pharmacies, not to this prescriber.

Other otolaryngology/facial plastic surgery in Houston

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →